This inventor holds 1 USPTO granted patent. Top assignee: Medivir Ab. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: S Christer Sahlberg: Innovator in Pharmaceutical Compounds
Introduction
S Christer Sahlberg is a notable inventor based in Hagersten, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of nucleosides and nucleotides. His work focuses on compounds that have therapeutic applications in treating viral infections.
Latest Patents
Sahlberg holds a patent for "5-substituted pyrimidine nucleosides and nucleotides." This invention is directed to compounds of formula (I), wherein various substituents are defined, including R^1 as OH or NH2, and R^2 as a heteroaromatic or aromatic substituent. The patent outlines the potential use of these compounds in pharmaceutical compositions for therapeutic treatment of virus infections. He has 1 patent to his name.
Career Highlights
S Christer Sahlberg is associated with Medivir AB, a company that specializes in the development of innovative antiviral therapies. His work at Medivir has been instrumental in advancing the understanding and treatment of viral infections through novel pharmaceutical compounds.
Collaborations
Sahlberg has collaborated with notable colleagues in his field, including Karl N Johansson and Hans C Malmberg. These collaborations have contributed to the advancement of research and development in antiviral therapies.
Conclusion
S Christer Sahlberg is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of viral infections significantly. His contributions to the field are noteworthy and reflect his commitment to innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile